Table 1 Baseline characteristics
From: Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement
Non-diabetic (N = 285) | Diabetic (N = 158) | P-value | ||
|---|---|---|---|---|
NIDDM (N = 114) | IDDM (N = 44) | |||
Age | 81.8 ± 7.5 | 79.8 ± 7.5 | 79.4 ± 7.7 | 0.016 |
Male | 128 (46) | 53 (46) | 23 (52) | 0.71 |
Hemoglobin | 11.5 (1.4) | 11.6 (1.4) | 12.6 (2.2) | 0.18 |
Glucose | 91 (13) | 97 (21) | 95 (34) | 0.21 |
Renal dysfunction | 46 (17) | 21 (20) | 23 (59) | <0.001 |
Hypertension | 232 (84) | 103 (94) | 34 (83) | 0.032 |
Dyslipidemia | 199 (72) | 90 (83) | 34 (85) | 0.036 |
Coronary artery disease | 124 (46) | 48 (45) | 24 (60) | 0.22 |
CHF-NYHA class III–IV | 165 (58) | 62 (54) | 23 (52) | 0.64 |
Atrial fibrillation/flutter | 66 (27) | 29 (28) | 13 (33) | 0.71 |
Peripheral vascular disease | 33 (12) | 13 (12) | 6 (15) | 0.85 |
Current smoker | 11 (4) | 2 (2) | 2 (5) | 0.53 |
COPD | 41 (15) | 19 (18) | 11 (28) | 0.13 |
s/p CABG | 57 (21) | 22 (21) | 10 (26) | 0.8 |
s/p PCI | 73 (27) | 30 (29) | 14 (36) | 0.55 |
Pacemaker | 21 (8) | 7 (7) | 2 (5) | 0.79 |
STS mortality | 5.3 ± 3.7 | 5.2 ± 2.9 | 7.6 ± 5.6 | 0.21 |
EUROSCORE 2 | 4.9 ± 5.1 | 4.7 ± 5.3 | 9.1 ± 8.7 | 0.16 |
HbA1c | 5.7 ± 0.43 | 6.8 ± 1.00 | 7.9 ± 1.47 | <0.001 |